A Call for Systemic Advancement in Feline Diabetes Care: Addressing Monitoring, Injection, and Veterinary Support Deficiencies

March 19, 2026 – The intricate and often emotionally taxing journey of managing feline diabetes has been brought into sharp focus by the firsthand account of Katia Colitti, a Ukrainian-American lawyer and animal welfare expert. Colitti’s experience caring for her beloved cat, Mosi, who was diagnosed with diabetes at the age of 17 and lived for four more years, underscores critical shortcomings in current feline diabetes care protocols, technology, and veterinary support. Her compelling narrative, shared on the EveryCat Health Foundation platform, highlights an urgent need for targeted innovations and standardized educational resources to alleviate the considerable stress placed on both diabetic cats and their dedicated caregivers. This article delves into the specific challenges identified by Colitti and explores the broader implications for veterinary medicine and pet owner advocacy.

The Expanding Landscape of Feline Diabetes Mellitus

Feline diabetes mellitus is a chronic metabolic disorder characterized by the body’s inability to produce or properly use insulin, leading to elevated blood glucose (sugar) levels. The prevalence of feline diabetes is a growing concern, with estimates suggesting it affects approximately 1 in 200 cats, a figure that some studies indicate may be increasing. Risk factors mirror those in humans, including obesity, advanced age, physical inactivity, and certain medications like corticosteroids. If left untreated or poorly managed, feline diabetes can lead to severe complications such as diabetic neuropathy (nerve damage, often affecting hind limbs), cataracts, and potentially life-threatening diabetic ketoacidosis (DKA), a metabolic emergency.

The primary goal of diabetes management in cats is to regulate blood glucose levels within a safe range, prevent the development of complications, and improve the animal’s quality of life. This typically involves a regimen of daily insulin injections, a specialized diet, and consistent monitoring of blood glucose. A unique aspect of feline diabetes, compared to its canine counterpart, is the potential for diabetic remission, particularly if aggressive and consistent treatment is initiated early after diagnosis. This prospect, however, hinges on tight glycemic control and diligent owner compliance, which can be profoundly challenging given the current limitations in veterinary resources and technology.

Mosi’s Journey: A Chronology of Caregiving Challenges

Katia Colitti’s four years as Mosi’s caregiver following her diagnosis at 17 provide a poignant chronology of the practical and emotional difficulties inherent in managing feline diabetes. Despite Colitti’s proactive approach, dedication, and consistent engagement with a large, reputable veterinary clinic that included a diabetes specialist, her journey was marked by persistent obstacles. These challenges, she contends, are not unique to her experience but represent systemic deficiencies that demand attention and resolution. Colitti’s observations coalesce into three critical areas: the arduous process of glucose monitoring, the complexities of insulin administration, and the perceived gaps in consistent, comprehensive veterinary guidance.

The Agony of Glucose Monitoring: A Plea for Feline-Specific Technology

Colitti’s most significant and emotionally taxing struggles revolved around blood glucose monitoring. Traditional methods, involving the collection of blood samples from a cat’s ears or toes, proved consistently difficult and distressing. For toe sampling, the requirement of a relatively large-gauge needle to obtain sufficient blood was a technique Colitti was never comfortable performing, given the inherent delicacy of a cat’s paw. Ear sampling, while often presented as a more accessible alternative, was "easier" only in a relative sense. The procedure necessitated a sequence of meticulous steps: coaxing Mosi to remain calm, gently warming her ear (without overheating, to avoid excessive bleeding), applying a tiny amount of Vaseline to prevent blood dispersion into the fur, and then carefully pricking near a vein. The subsequent challenge involved swiftly transferring a sufficient blood drop onto a glucometer strip before it clotted, all while maintaining the cat’s stillness.

Colitti recounts numerous instances where the process failed, resulting in insufficient blood, error messages from the glucometer, and the need for multiple attempts. This repetitive cycle of pricking, often causing Mosi to wince, generated immense emotional distress for Colitti, who grappled with the paradox of needing to inflict minor pain to provide essential care. The physical toll on Mosi was palpable; her ears developed scarring over time, a testament to the frequent punctures. In a particularly devastating incident late in Mosi’s life, an accidental strike of a vein at the tip of her left ear led to severe damage, necrosis, and eventually the spontaneous loss of the ear tip. This traumatic event, which thankfully did not require surgery due to Mosi’s fragile state, profoundly impacted Colitti.

The challenges extended to attempts at utilizing continuous glucose monitors (CGMs), devices that have revolutionized human diabetes management by providing real-time glucose trends. Colitti’s high hopes for human-designed CGMs, used off-label, were repeatedly dashed. She tried three different monitors, each requiring the stressful procedures of shaving and applying surgical glue to Mosi’s fragile skin, followed by securing the device with a small shirt that restricted Mosi’s already limited movement due to arthritis. Crucially, these devices consistently malfunctioned, either failing to activate or ceasing to work well before their advertised 14-day lifespan. This cycle of invasive application, device failure, and difficult removal proved unsustainable and unjustifiable for Mosi’s well-being.

Colitti’s experience with CGMs underscores a significant technological gap: the absence of devices specifically designed for feline physiology. She advocates for cat-specific CGMs that are "tailored to feline body morphology, smaller, lighter, and gentle enough for thin or elderly cats," and, critically, are "easy to apply and remove at home" and "work reliably." Such devices would not only reduce stress but also provide invaluable data, potentially revealing phenomena like the "Somogyi effect" (rebound hyperglycemia following an insulin-induced low) or the "dawn phenomenon" (a natural rise in blood glucose in the morning), which are often missed with intermittent spot checks and can significantly impact treatment efficacy.

The need for species-specific instrumentation extends to glucometers themselves. Colitti initially used a human glucometer, a brand also used by her clinic. She later discovered that due to physiological differences in blood cell composition and glucose metabolism between species, animal-calibrated meters may provide more accurate readings for cats. Her attempt to switch to an animal-calibrated device was thwarted by confusing instructions and an unfamiliar scale, forcing her to abandon it. This highlights the urgent need for user-friendly, cat-specific glucometers that provide accurate data without requiring caregivers to navigate complex technical hurdles.

Complexities of Insulin Administration: Adapting to the Frail Patient

Insulin injections, the daily routine for diabetic cats, also presented evolving and often perplexing difficulties for Colitti. Initially, a rhythm was established, but Mosi’s discomfort with injections in different areas meant that alternating injection sites – a common recommendation to prevent localized tissue damage and ensure consistent insulin absorption – was not a viable option. This limited her to a few preferred sites, increasing the potential for long-term skin issues.

The prospect of using injection pens, which can simplify the dosing process, was also quickly dismissed. Mosi suffered from an auditory disorder, and the loud clicking noise produced by such pens triggered seizures. This particular challenge highlights the necessity for medical devices to consider the diverse sensory sensitivities and comorbidities of individual animals, rather than assuming a one-size-fits-all design.

The most acute injection challenges emerged during Mosi’s final year, as significant weight loss rendered her increasingly frail and thin. Colitti frequently found herself accidentally injecting insulin into Mosi’s fur rather than subcutaneously. Standard veterinary advice rigidly dictates against re-injecting in such scenarios due to the life-threatening risk of hypoglycemia from a potential double dose. Colitti, terrified of harming Mosi, adhered strictly to this guideline, even when she was almost certain no insulin had been delivered. This dilemma places caregivers in an impossible position: risk a potentially fatal overdose versus risk inadequate treatment and persistent hyperglycemia.

The instructional resources available to caregivers often failed to address the practical realities of managing a geriatric or cachectic cat. Most instructional videos, as Colitti observed, feature "cats of average weight with generous skin folds," which provide ample tissue for injection. These examples offered little practical guidance for injecting a thin, elderly cat with minimal subcutaneous fat. The eventual, albeit inconvenient, solution was to shave the area between Mosi’s shoulder blades, which became the only reliable method to ensure proper insulin delivery. Colitti’s experience makes a clear case for "better, quieter injection pens designed for feline use" and, critically, "clear, practical guidance for injecting thin or frail cats, not just easy, perfect examples." This emphasizes the imperative for care instructions to reflect the diverse and often challenging realities of an aging and frequently ill feline patient population.

The Imperative for Enhanced Veterinary Guidance and Education

Beyond the technological and procedural hurdles, Colitti consistently felt a significant deficit in comprehensive and consistent veterinary guidance. Despite Mosi receiving care at a reputable, specialized clinic, information provided at initial consultations was sometimes incomplete or, upon later research, found to be conflicting. For example, Colitti was initially advised to reuse syringes twice, a practice she followed for years before growing concerned about insulin contamination and ceasing the habit. Subsequent research revealed conflicting information regarding needle reuse, underscoring a critical need for standardized, evidence-based recommendations that are clearly communicated to pet owners.

Other vital pieces of information were either omitted from initial briefings or discovered through laborious personal research. Colitti learned about the technique of holding the needle bevel-side up for smoother insertion and reduced discomfort not from her veterinary team, but from online sources. Similarly, the crucial instruction to discard insulin vials after 20 days of use – a detail essential for maintaining insulin efficacy and sterility – was only discovered by meticulously deciphering "tiny print on the vial" with a magnifying glass. Perhaps most profoundly, Colitti and her family learned too late that early, tightly regulated treatment in the initial months after diagnosis can sometimes lead to remission in cats. This missed opportunity for a potentially life-altering outcome highlights the significant impact of informational gaps at critical junctures.

Colitti’s experience, despite being a "dedicated, proactive, and well-resourced caregiver" who frequently sought veterinary assistance, underscores a broader systemic issue: many caregivers of animals with chronic illnesses often feel isolated in their struggle. She proposes tangible improvements for the veterinary community: "clearer, more comprehensive information at diagnosis and more through structured follow-ups." Furthermore, for chronic conditions requiring extensive, ongoing care, Colitti suggests that clinics could offer "video consultations or subscription-style access to a veterinarian or veterinary nurse for ongoing support." This vision aligns with emerging trends in telehealth and personalized medicine, recognizing the continuous, dynamic nature of chronic disease management and the need for adaptable support systems.

Broader Implications and the Path Forward

Catalyzing Technological Innovation for Veterinary Medicine: Colitti’s heartfelt plea for cat-specific CGMs and glucometers highlights a critical void in the veterinary medical device market. The development of species-specific technology is frequently hampered by the significantly smaller market size compared to human medicine, which can make the return on investment less attractive for commercial manufacturers. However, the increasing prevalence of feline diabetes, coupled with the growing willingness of pet owners to invest in advanced and compassionate care for their companions, indicates a viable, albeit specialized, market. Innovations in miniaturization, biocompatible materials, and wireless data transmission, which are already standard in human medical technology, could be adapted for feline use. Research funding from non-profit organizations like EveryCat Health Foundation plays an indispensable role in de-risking such ventures and demonstrating market demand, thereby incentivizing commercial development.

Advancing Veterinary Education and Support Models: The inconsistencies and informational gaps in veterinary guidance described by Colitti are not isolated incidents but reflect broader challenges within veterinary education and client communication strategies. Veterinarians undergo extensive training in diagnosis and treatment, but often face significant time constraints in busy clinical settings and may lack standardized, comprehensive educational materials specifically designed for effective chronic disease management by pet owners. Professional organizations, such as the American Association of Feline Practitioners (AAFP) and the International Society of Feline Medicine (ISFM), continuously update their guidelines for optimal feline care, but the effective dissemination and consistent implementation of these into day-to-day client education remain critical areas for improvement.

The progressive models proposed by Colitti, such as video consultations and subscription-style access to veterinary professionals, represent a pivotal shift towards more continuous, accessible, and personalized chronic care management. Telemedicine has witnessed rapid and widespread adoption in human healthcare and offers similar transformative potential in veterinary medicine, particularly for conditions requiring frequent monitoring, regular adjustments to treatment plans, and ongoing owner support. This approach could significantly empower caregivers with real-time guidance, reduce the physical and emotional stress of frequent clinic visits for frail or anxious animals, and ultimately lead to more consistent adherence to treatment protocols and better long-term health outcomes.

The Indispensable Role of Advocacy and Research Funding: Katia Colitti’s eloquent and deeply personal articulation of her caregiving challenges serves as a powerful call to action for the entire veterinary community and for pet owners globally. Her story resonates with the experiences of countless dedicated caregivers who navigate similar struggles with chronic feline illnesses. Organizations like EveryCat Health Foundation are instrumental in driving meaningful change by funding targeted research. Their 2026 "Springing into Action" campaign, specifically supporting The O’Malley Fund for Diabetes and Endocrinopathies, is designed to address these very issues. By investing in studies that explore novel monitoring technologies, refine insulin delivery systems, and develop enhanced, accessible educational strategies, these foundations lay the crucial groundwork for a future where feline diabetes management is not only less burdensome but also significantly more effective and compassionate. The collective efforts of researchers, veterinary professionals, technology developers, and dedicated caregivers, amplified by the vital support of philanthropic foundations, are essential to transform the landscape of feline diabetes care for the betterment of cats and their human companions.

About the Author:
Katia Colitti is a Ukrainian-American lawyer currently residing and working in Belgium. A lifelong and passionate advocate for animals, she has generously shared her home with three rescue cats for nearly two decades. Her robust academic background includes an MSc in International Animal Welfare, Ethics, and Law from The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, and she has a distinguished record of publishing and presenting extensively on complex animal welfare issues. Her deep personal experience and profound professional interest in caring for geriatric and diabetic cats lend significant authority and empathy to her observations and recommendations for advancing feline health care.